Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Oct 7, 2020 7:00 AM ET

Global Stroke Diagnostics and Therapeutics Market is Set for a Rapid Growth and is Expected to Reach around USD 31.00 Billion by 2021


iCrowd Newswire - Oct 7, 2020

Zion Market Research has published a new report titled “Stroke Diagnostics and Therapeutics Market by Diagnostics (Magnetic Resonance Imaging, Computed Tomography Scan, Electrocardiography Carotid Ultrasound, Cerebral Angiography and Others), by Therapeutics (Tissue Plasminogen Activator, Antiplatelet, Antihypertensive, and Anticoagulant), and by Application (Haemorrhagic Stroke and Ischemic Stroke) – Global Industry Perspective, Comprehensive Analysis and Forecast, 2019-2026.” According to the report, the Stroke Diagnostics and Therapeutics Market accounted for USD 27.08 Billion in 2019 and is expected to reach USD 43.48 Billion by 2026, growing at a CAGR of around 7% between 2020 and 2026.

Get Free Sample Of Report – https://www.zionmarketresearch.com/sample/stroke-diagnostics-therapeutics-market

Increasing aging population to drive the stroke diagnostics and therapeutics market in the years to come
Stroke diagnostics and therapeutics market have been paced by the huge patient pool in addition to the increasing aging population all over the world, as per analysts at Zion Market Research. In addition to this, rising number of the aged population in western nations particularly in Europe is the major boosting factor for powering the development of stroke diagnostics and therapeutics market. In addition to this, atrial fibrillation, hypertension, and coronary heart diseases are the helping hands that promote the development of stroke diagnostics and therapeutics market. On the other hand, the high price of treatment directly impacts the development of stroke diagnostics and therapeutics market. Moreover, shortage of transparent reimbursement practices is also expected to affect the development of stroke diagnostics and therapeutics market. Nevertheless, in-progress R&D in the healthcare industry techs is likely to open growth opportunities for the stroke diagnostics and therapeutics market in the years to come. For instance, in July 2018, it advancements in the therapeutic and diagnostic employment of carbon nanomaterials and liposomes in ischemic stroke were made.

North America to lead stroke diagnostics and therapeutics market in forecast period
On the basis of application, the global stroke diagnostics and therapeutics market is divided into 2 types namely ischemic stroke and hemorrhagic stroke. In 2019, Ischemic stroke ruled the application division of global stroke diagnostics and therapeutics market. This division is likely to stay on the hike in the years to come. The development of stroke diagnostics and therapeutics market is credited due to huge occurrence of ischemic stroke in aged patient.

In terms of regions, North America in 2019 was the leading area for stroke diagnostics and therapeutics market in terms of income chased by Europe. This was due to the accessibility of advanced tech and infrastructure. In addition to this, stroke diagnostics and therapeutics market have huge growth avenues in emerging regions such as Latin America and Asia Pacific owing to the public awareness, huge patient base, government initiatives, increase disposable income, and healthcare infrastructure.

The key participants operating in the global stroke diagnostics and therapeutics market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips N.V., GE Healthcare, Siemens AG, Stryker Corporation, Genentech, Inc. and Merck & Co., Inc.

The global stroke diagnostics and therapeutics market is segmented as follows:

By Diagnostics

By Therapeutics

By Application

By Region

To view TOC of this report – https://www.zionmarketresearch.com/toc/stroke-diagnostics-therapeutics-market



Contact Information:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com






Keywords:    Global Stroke Diagnostics and Therapeutics Market

Tags:    IPS, Reportedtimes, iCN Internal Distribution, Research Newswire, English